We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

First ECMO System Integrated with Non-Invasive Blood Sensor Technology to Treat Heart and Lung Failure

By HospiMedica International staff writers
Posted on 12 Jul 2022
Print article
Image: The Liby system is designed to be a new generation ECMO system (Photo courtesy of Inspira Technologies)
Image: The Liby system is designed to be a new generation ECMO system (Photo courtesy of Inspira Technologies)

Extracorporeal membrane oxygenation (ECMO) is an advanced form of life support used to treat patients with life-threatening heart and lung failure. ECMO systems are designed to directly oxygenate and remove carbon dioxide from a patient's blood, replacing the entire lung function by circulating all of the patient's blood (5-7 liters) every minute. As a last resort procedure, it requires the patient to be confined to ICUs and is associated with a high level of medical risks. Now, for the first time, a new generation ECMO system integrated with non-invasive blood sensor technology offers potential advantages that may improve usability and patient care.

Inspira Technologies (Ra'anana, Israel) is developing the Liby System, a new generation ECMO system that includes several new features and capabilities as well as a new approach to medical device designs, including a large touchscreen and novel colorful graphical representation that increases the visibility, scope and functionality of data displayed to the medical staff. With its small footprint and lightweight characteristics, the Liby system is being designed with a rapid style aerospace-grade aluminum structure to be both lightweight and highly durable, and will be equipped with long battery life, a contributing factor to making the Liby system suitable for patient mobility within hospitals and for transportation of patients to hospitals in ambulances.

The Liby system is also expected to be the first system designed for integration with the company's recently revealed non-invasive HYLA blood sensor technology. The HYLA non-invasive blood sensor is attached to the outer walls of a tube that has blood flowing through it and is being designed as a new platform based on key technologies being developed for Inspira’s ART system, designed to reduce the need for invasive mechanical ventilation. The HYLA blood sensor is designed to minimize the need for invasive medical procedures with the intention of reducing risks, complications and costs. The addition of the HYLA to patients treated with the Liby system, would potentially allow for the real-time and continuous monitoring of patient condition to alert physicians of immediate signs of changes in a patient's clinical condition. The Liby system is expected to be submitted to the FDA for approval during the first half of 2023. Subject to FDA approval, the Liby system's expected regulatory pathway is intended to be designated as a Class II 510 (K), meaning it may not require human trials.

"The Liby system is intended to target one of three market segments within Inspira Technologies product scope,” said Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies. "The Liby system is expected to introduce the next generation of ECMO within Intensive Care Units (ICUs), due to its practical advantages, designed to improve durability, patient mobility both within the hospital or via ambulance, and ease of use. I believe that these are important advantages for medical teams within over-crowded ICUs, targeting to improve patient outcomes."

Related Links:
Inspira Technologies 


Print article
Radcal

Channels

Surgical Techniques

view channel
Image: The NaoTrac CE-certified neurosurgical navigation robot has received TFDA approval (Photo courtesy of Brain Navi Biotechnology)

Neurosurgical Navigation Robot Combines AI and Machine Vision to Streamline Procedures

Amidst the increasing demand for minimally invasive surgery, neuro-navigation has become standard in neurosurgery worldwide. Currently, most navigation systems use a “vision-based optical tracking system”... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more

Business

view channel
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)

Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure

Capsule endoscopy is generally a non-invasive technique that enables complete examination of the gastrointestinal tract with the use of the disposable and wireless device known as the video capsule.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.